Jacobs Bruce N. bought KYMR
June 30, 2026 · Form 4 insider transaction
Jacobs Bruce N. bought 61,378 shares of Kymera Therapeutics, Inc. at $5.33 per share, a transaction worth $327.1K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
61,378
Price
$5.33
Total value
$327.1K
InsiderJacobs Bruce N.
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 30, 2026
Filing dateJuly 2, 2026
Shares owned after321,992
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan dated March 23, 2026 adopted by the reporting person.; This number includes 373 shares acquired under the Registrant's employee stock purchase plan.